{"filing":{"accession_number":"0001628280-26-043210","cik":"0001041024","ticker":"RMTI","company_name":"ROCKWELL MEDICAL, INC.","form":"8-K","filing_date":"2026-06-15","report_date":null,"primary_document":"rmti-20260612.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/rmti-20260612.htm"},"events":[{"id":11077,"run_id":9713,"accession_number":"0001628280-26-043210","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from Rockwell Medical's June 12, 2026 Annual Meeting of Stockholders. The filing presents voting tallies for four proposals: election of Class II directors (Joseph Dawson and Joan Lau, Ph.D.), advisory approval of named executive officer compensation, ratification of EisnerAmper LLP as independent auditor, and approval of a reverse stock split amendment. The materiality is high given the reverse stock split approval and auditor ratification are substantive corporate governance matters affecting investors.","company_name":"ROCKWELL MEDICAL, INC.","ticker":"RMTI","filing_date":"2026-06-15","form":"8-K","submitted_at":null,"items":[{"id":7574,"accession_number":"0001628280-26-043210","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Rockwell Medical's June 12, 2026 Annual Meeting of Stockholders. The filing presents voting tallies for four proposals: election of Class II directors (Joseph Dawson and Joan Lau, Ph.D.), advisory approval of named executive officer compensation, ratification of EisnerAmper LLP as independent auditor, and approval of a reverse stock split amendment. The materiality is high given the reverse stock split approval and auditor ratification are substantive corporate governance matters affecting investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T20:29:05.611531+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7574,"accession_number":"0001628280-26-043210","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Rockwell Medical's June 12, 2026 Annual Meeting of Stockholders. The filing presents voting tallies for four proposals: election of Class II directors (Joseph Dawson and Joan Lau, Ph.D.), advisory approval of named executive officer compensation, ratification of EisnerAmper LLP as independent auditor, and approval of a reverse stock split amendment. The materiality is high given the reverse stock split approval and auditor ratification are substantive corporate governance matters affecting investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T20:29:05.611531+00:00","company_name":"ROCKWELL MEDICAL, INC.","ticker":"RMTI","filing_date":"2026-06-15"}]}